Skip to content

Clinical trials

Phase 4 Multiple Sclerosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Phase: Phase 4 Country / region: United States Clear all

75 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20033
20043
20051
20062
20071
20082
20091
20103
20111
20122
20138
20142
20157
20164
20174
20182
20195
20204
20215
20224
20231
20242
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44
Terminated11
Recruiting6
Active, not recruiting5
Unknown status4
Withdrawn4
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen5
Novartis Pharmaceuticals5
Brown, Theodore R., M.D., MPH3
Multiple Sclerosis Center of Northeastern New York3
University of Colorado, Denver3
University of Rochester3
University of Texas Southwestern Medical Center3
EMD Serono2
Genentech, Inc.2
Hoffmann-La Roche2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis75
Multiple Sclerosis, Relapsing-Remitting7
Optic Neuritis3
Recurrence3
Demyelinating Diseases2
Fatigue2
Brain Concussion1
Brain Neoplasms1
COVID-191
Cerebellar Diseases1

Trials

Showing 1 to 25 of 75. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.